Interview with Marko Dolzan, President, Polfa Lodz
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
Address: ul. Drewnowska 43/55, 91-002 Lodz
Tel: +48 42 654 00 70
Web: http://www.polfa-lodz.com/
For 75 years, we have been specialising in producing top quality medicinal products, dietary supplements and cosmetics. Thanks to the trust of physicians and pharmacists, our products can be found in every Polish home.
Our strongest desire is to perfect our preparations and to make efforts to increase their safety and efficacy. We are constantly striving to maintain the highest production standards – our production processes comply with GMP, HACCP and ISO standards.
In order to maintain continuous development, we merged with SENSILAB Sp. z o.o. in 2008.
We are one of the leading drugs and dietary supplements manufacturers in Poland. Every year over 5,000,000 packets of our products are shipped to our customers. We offer over 50 different preparations. We are a leading manufacturer of calcium preparations based on the most easily absorbable form of calcium.
We are a pharmaceutical manufacturer which – apart from producing its own preparations – also provides contracted production services. Depending on the demand, our R&D department can develop products to be manufactured under a customer’s brand name. Owing to our modern and highly efficient equipment, we can fulfil your orders promptly. We take production services for our partners very seriously. We treat every enquiry on an individual basis, which results in the comprehensive service that our company can offer.
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
Philippe Coudiere, general manager of Pierre Fabre Dermo-cosmetics Poland, highlights the key partnerships the company has nurtured with pharmacists and dermatologists and the importance of clinical data for their products.…
Artur Chabowski, president of Mabion, a pioneer Polish biotech player, discusses the historic partnership of their product, MabionCD20 with Mylan for the EU and Baltic states and the opportunities this…
Markus Sieger, CEO of Polpharma, outlines his global strategy for the company, focused on OTC and CHC, internationalization and a strong R&D strategy to push forward biosimilars. Furthermore, he highlights…
Mariusz Ignatowicz, PwC healthcare sector leader for CEE, discusses the funding of the Polish healthcare ecosystem and the need to find an alternative payer in the long-term Additionally, he highlights…
Colm Murphy, general plant manager of Anpharm, a key European production site for the Servier group, highlights major investments in recent years, such as the state-of-the-art QC Lab, and his…
Krzysztof Kołodziejski, country manager of Santen Poland, discusses the strategy he put in place to modernize the business culture of the affiliate and how this has led to great success.…
Jarosław Król, president of Polfa Tarchomin, highlights the strategic moves he has made to stabilise the company and the need to deliver a new, fresh portfolio to drive forward profit.…
Andrzej Tarnkowski, founder and owner of Antar, a Polish success story within the orthopaedic field, discusses the company’s successful international expansion into various markets, including Germany, while highlighting the opening…
Joanna Drewla, general manager of Servier Poland, discusses Polish healthcare challenges and looks at areas for improvement to create a sustainable balance for market access of innovative treatments. Furthermore, she…
Stefan Jaworski-Martycz, country manager Poland and CEE Cluster Lead of Théa, a leading French ophthalmology company, discusses the intricacies of the Polish ophthalmology environment and the key steps for the…
Dorota Hryniewiecka-Firlej, president of Pfizer Poland, discusses the current state of the Polish innovation landscape and importance of a tight-knit relationship between the innovative pharmaceutical market and the government for…
Robert Bitner, country manager of Galderma Poland, give his first impressions of the Polish dermatology landscape and how his past experiences have prepared him for the challenges ahead. Additionally, he…
See our Cookie Privacy Policy Here